Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $40.2 Million - $44.5 Million
-700,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $38.4 Million - $44.9 Million
700,000 New
700,000 $41.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Leonard Green & Partners, L.P. Portfolio

Follow Leonard Green & Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leonard Green & Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Leonard Green & Partners, L.P. with notifications on news.